Related coverage linked through entity extraction aliases.
Jun 10, 2026
Trial: VPM1002/Immuvac show limited overall TB protection but up to 50.4% efficacy vs extrapulmonary TB. Modeling: blocking asymptomatic TB key to long-term vaccine impact. Also: STEP-TB safety study and CDC Asia funding.
Jul 15, 2026
A single-center study of 95 chronic kidney disease patients on hemodialysis found the Cy-TB skin test agreed completely with standard IGRA testing for latent tuberculosis, with an overall prevalence of 4.2%. Early dialysis phase (<6 months) was a strong predictor of positivity, suggesting a potential priority screening window, though larger confirmatory studies are needed.
